#ThinkSabio Latest News Can-Fite anti-Obesity Drug Namodenoson Received Patent Allowance in Australia Post navigation ThinkSabio-Stocks-Simplified-SEC-Update-ATNM (04-NOV-2024)ThinkSabio-Stocks-Simplified-SEC-Update-BCRX (04-NOV-2024)